Windlas Biotech has announced a board meeting to consider the financial results for the quarter and half-year. Its registrar and share transfer agent, MUFG Intime India, confirmed no dematerialization requests were received during the period. The company holds no physical shares, reflecting full dematerialization of equity, which streamlines shareholder record management and indicates adherence to modern equity practices beneficial for investors.